Year archive

CanSino Biologics Inc. — 2025 filings

All 72 regulatory filings released by CanSino Biologics Inc. (6185) in 2025, sourced directly from the official regulator.

72 Filings

2025 Period

2025 filings (72)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR DTCP-HIB-MCV4 COMBINED VACCINE Regulatory Filings	2025-12-19	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-12-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-27	English
List of Directors and their Roles and Functions Board/Management Information	2025-11-27	English
Articles of Association Governance Information	2025-11-27	English
POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; ELECTION OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND ADJUSTMENT TO THE COMPOSIT Declaration of Voting Results & Voting Rights Announcements	2025-11-27	English
Next Day Disclosure Return Transaction in Own Shares	2025-11-27	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-26	English
VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE I CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR INHALED TB BOOSTER IN INDONESIA Regulatory Filings	2025-11-13	English
Form of Proxy for use at the 2025 Second Extraordinary General Meeting to be held on Thursday, November 27, 2025 Proxy Solicitation & Information Statement	2025-11-11	English
NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-11-11	English
2025 SECOND EGM CIRCULAR Proxy Solicitation & Information Statement	2025-11-11	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-07	English
INSIDE INFORMATION - USING RESERVES TO OFFSET LOSSES Capital/Financing Update	2025-11-07	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-11-06	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-10-27	English
TERMS OF REFERENCE FOR THE REMUNERATION AND ASSESSMENT COMMITTEE OF THE BOARD Governance Information	2025-10-27	English
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF THE BOARD Governance Information	2025-10-27	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD Governance Information	2025-10-27	English
(1) PROPOSED CANCELLATION OF THE BOARD OF SUPERVISORS AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE RULES OF PROCEDURES; (2) PROPOSED AMENDMENTS TO THE CORPORATE GOVERNANCE RULES; (3 Board/Management Information	2025-10-27	English
THIRD QUARTERLY REPORT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 Interim / Quarterly Report 9M 2025	2025-10-27	English
POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Declaration of Voting Results & Voting Rights Announcements	2025-10-23	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-10-23	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-10-17	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-10-15	English
Revised Form of Proxy for use at the 2025 First Extraordinary General Meeting to be held on Thursday, October 23, 2025 Proxy Solicitation & Information Statement	2025-10-10	English
RULES RELATING TO THE 2025 H SHARE OPTION SCHEME Regulatory Filings	2025-10-08	English
THE 2025 RESTRICTED A SHARE INCENTIVE SCHEME Regulatory Filings	2025-10-08	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-10-06	English
Form of Proxy for use at the 2025 First Extraordinary General Meeting to be held on Thursday, October 23, 2025 Proxy Solicitation & Information Statement	2025-10-06	English
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2025-10-06	English
2025 FIRST EGM CIRCULAR Proxy Solicitation & Information Statement	2025-10-06	English
SUPPLEMENTAL ANNOUNCEMENT Share Issue/Capital Change	2025-09-30	English
(1) PROPOSED ADOPTION OF THE 2025 A SHARE INCENTIVE SCHEME (2) PROPOSED ADOPTION OF THE 2025 H SHARE OPTION SCHEME AND (3) GRANT OF H SHARE OPTIONS UNDER THE 2025 H SHARE OPTION SCHEME Share Issue/Capital Change	2025-09-26	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-26	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-18	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-02	English
Monthly Return of Equity Issuer on Movements in Securities Share Issue/Capital Change	2025-09-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-20	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-20	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-08-06	English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT POLIOMYELITIS VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA Regulatory Filings	2025-07-16	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-07-03	English
INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO PCV13i Regulatory Filings	2025-06-20	English
POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING Declaration of Voting Results & Voting Rights Announcements	2025-06-04	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-06-04	English
VOLUNTARY ANNOUNCEMENT - INHALED TB BOOSTER OBTAINS CLINICAL TRIAL APPROVAL IN INDONESIA Regulatory Filings	2025-05-15	English
Form of Proxy for use at the 2024 Annual General Meeting to be held on Wednesday, June 4, 2025 Proxy Solicitation & Information Statement	2025-05-13	English
NOTICE OF 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-13	English
2024 AGM CIRCULAR Proxy Solicitation & Information Statement	2025-05-13	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-05-08	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-29	English
FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 2025 Interim / Quarterly Report Q1 2025	2025-04-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-22	English
Letter to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2025-04-16	English
Letter to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form Regulatory Filings	2025-04-16	English
2024 Environmental, Social and Governance & Corporate Social Responsibility Report Environmental & Social Information	2025-04-16	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-16	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-04-15	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-04-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-25	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 Annual Report FY 2024	2025-03-25	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-12	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-03-04	English
INSIDE INFORMATION - UPDATES ON 2024 PRELIMINARY ANNUAL RESULTS Earnings Release FY 2024	2025-02-27	English
VOLUNTARY ANNOUNCEMENT - DTCP-HIB-MCV4 COMBINED VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA Regulatory Filings	2025-02-24	English
VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR DTCP INFANT Regulatory Filings	2025-02-07	English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TETANUS VACCINE Regulatory Filings	2025-02-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-02-06	English
INSIDE INFORMATION - RESULTS FORECAST FOR THE YEAR 2024 Earnings Release FY 2024	2025-01-17	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2025-01-03	English

Filings by year

2026 28 filings
2025 72 filings
2024 99 filings
2023 153 filings
2022 186 filings
2021 166 filings
2020 101 filings
2019 62 filings
2018 4 filings